NAOV

NanoVibronix, Inc. Common Stock
Data: 2025-12-11
$4.02
Price
-10.47%
Change
$162.5
52W High
$0.667
52W Low

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Quick Stats

49.3

AI Score

HOLD

1.26

Volume Ratio

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

NAOV Stock Summary

Last updated

NAOV is currently trading at $4.02, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $0.667 to $162.5.

Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NAOV at 49.3/100 with a HOLD recommendation.

NAOV Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NAOV Price vs Max Options Open Interest
NAOV Max Change In Options Open Interest

NAOV Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAOV Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAOV Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NAOV Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

NanoVibronix, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

NAOV Moving Averages Analysis

NAOV (NanoVibronix, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated

Days MA

NAOV Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 4.7 million
Earnings/Share ($) -51.81
Net Proft Margin (%) -2.5192
Dividend/Share ($) --
EPS Estimate Current Year ($) 0
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) 10.5
Most Recent Quarter